Ex parte LIN et al. - Page 3




                     Appeal No. 1997-4138                                                                                                                                           
                     Application No. 08/384,681                                                                                                                                     


                                          f.        washing away unbound conjugate;                                                                                                 
                                          g.        applying onto said discrete location a drop of a second fluid                                                                   
                     comprising a substrate reactable with said enzyme at room temperature to form within                                                                           
                     about five minutes a colored precipitate visually detectable against said opaque carrier;                                                                      
                     and                                                                                                                                                            
                                          h.        visually ascertaining the presence or absence of the colored                                                                    
                     precipitate as indicative of the presence or absence of said at least one component to be                                                                      
                     detected.                                                                                                                                                      
                               56.        An analytical device for use in a sandwich enzyme immunoassay for                                                                         
                     detecting the presence in a body fluid of at least one component to be detected selected                                                                       
                     from the group consisting of antigens, antibodies and haptens, consisting essentially of an                                                                    
                     inert, opaque plastic carrier having a flat, hydrophobic surface that is non-absorbent to                                                                      
                     said antibodies, antigens and haptens and to enzymes having deposited directly thereon                                                                         
                     an insolubilized specific binding partner of the at least one component to be detected in                                                                      
                     the form of spots of from 1 to 4 mm in diameter in discrete, visually locatable locations.                                                                     
                                                       1                                                                                                                            
                               The references  relied upon by the examiner are:                                                                                                     
                     Fish et al. (Fish)                                             5,126,276                                  Jun.  30, 1992                                       
                     Towbin et al. (Towbin), "Immunoblotting and Dot Immunobinding -- Current Status and                                                                            
                     Outlook," Journal of Immunological Methods, vol. 72, pp. 313-340, 1984                                                                                         


                               1At page 11 of the Examiner's Answer, the examiner cites U.S. Patent 4,594,225 to                                                                    
                     Arai et al.  Since this reference was not included in the list of references relied upon and                                                                   
                     not included in the statement of the rejection, it is not clear whether the reference is relied                                                                
                     upon to establish the state of the prior art.  If it is relied upon to establish the state of the art                                                          
                     relative to a rejection under 35 U.S.C. § 103, the record should clearly indicate that it is so                                                                
                     relied upon and appellants given ample opportunity to respond thereto.  In view of the                                                                         
                     confusion as to the status of the examiner's reliance on this reference, we have not                                                                           
                     considered it in considering the issues raised by this appeal. When a reference is relied                                                                      
                     on to support a rejection even in a "minor capacity," ordinarily that reference should be                                                                      
                     positively included in the statement of rejection. In re Hoch, 428 F.2d 1341, 1342, n.3, 166                                                                   
                     USPQ 406, 407, n. 3 (CCPA 1970).                                                                                                                               

                                                                                         3                                                                                          





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007